Quick Summary

Uncaria rhynchophylla is a traditional Chinese medicinal herb with a long history of use, primarily for neurological disorders, hypertension, and inflammatory conditions linked to liver wind and liver yang rising. It contains monoterpenoid indole alkaloids and other bioactive compounds. Preclinical studies suggest potential neuroprotective, antihypertensive, immunomodulatory, antiviral, and anti-inflammatory activities. However, clinical evidence remains limited, and further high-quality trials are necessary to confirm its efficacy and safety.

What is it?

Uncaria Hook, derived from the plant Uncaria rhynchophylla, is a climbing vine native to China and used in traditional Chinese medicine (TCM). It is recognized for its unique hooked thorns and is commonly employed for cardiovascular, neurological, and inflammatory health support within TCM practice.

Traditional Uses

  • Calming liver wind and reducing liver yang rising symptoms
  • Management of neurological conditions such as tic disorders and epilepsy
  • Supporting blood pressure regulation
  • Reducing inflammation related to neuroinflammatory and systemic processes

Active Compounds

Key bioactive constituents include monoterpenoid indole alkaloids, which may contribute to its pharmacological effects. These compounds are studied for their potential to modulate neurotransmission, inflammation, and vascular function.

Potential Benefits with Evidence Levels

  • Tic Disorders: Traditional use supported by TCM prescription data indicates Uncaria rhynchophylla is frequently used for liver-soothing and wind-calming effects. Clinical validation and mechanistic studies are still pending. (Traditional use with some clinical data on usage patterns; no direct high-quality clinical trials)
  • Parkinson’s Disease and Other Neurodegenerative Diseases: Preclinical rodent studies suggest neuroprotective effects through inhibition of α-synuclein aggregation, attenuation of neuroinflammation, oxidative stress reduction, and improved mitochondrial function. (Preclinical evidence; absence of human clinical trials)
  • Hypertension: Included in multi-herb TCM formulas with potential antihypertensive effects via calcium channel antagonism and nitric oxide-mediated vasodilation. Direct evidence for Uncaria Hook alone is limited. (Indirect clinical evidence as part of multi-herb formulas; limited direct evidence)
  • Epilepsy: Traditional use and preclinical models implicate modulation of NMDA and AMPA receptors with anticonvulsant potential. Combined herbal and acupuncture treatments involving Uncaria species show promise in pediatric epilepsy, though specific effects are not isolated. (Preclinical and limited clinical trial data; requires more controlled clinical research)
  • Inflammation and Immune Modulation: Laboratory and animal studies indicate immunomodulatory and anti-inflammatory effects, possibly benefiting neuroinflammation and systemic inflammation through pathways such as TLR4/MyD88/NF-κB inhibition. (Preclinical and mechanistic studies)
  • Diabetic Peripheral Neuropathy: As part of multi-herb TCM treatments, preliminary clinical evidence suggests improvement in neurological function and symptom relief. (Indirect clinical evidence as part of multi-herb therapies)

Side Effects

No serious adverse events have been specifically attributed to Uncaria rhynchophylla in available clinical trials and meta-analyses. Adverse event rates in herbal treatments containing Uncaria were comparable to control groups. Some drugs with similar pharmacologic profiles showed potential pro-oxidative effects, but no direct adverse effects have been conclusively linked to Uncaria. Cautious interpretation is advised.

Drug Interactions

Currently, no specific drug interactions have been confirmed. However, since Uncaria rhynchophylla is metabolized via CYP3A4 and may affect calcium channels, theoretical interactions with CYP3A4 substrates and calcium channel blockers are possible and merit further investigation.

Who Should Avoid It

  • Individuals with known allergies to plants in the Rubiaceae family or to components of multi-herbal formulations containing Uncaria rhynchophylla
  • Pregnant or breastfeeding women, due to the absence of safety data for these populations

Evidence Limitations

  • The majority of evidence derives from preclinical studies or indirect clinical data within multi-herb formulations rather than isolated Uncaria rhynchophylla administration.
  • There is a lack of high-quality randomized controlled trials focused solely on Uncaria rhynchophylla, limiting conclusions about clinical efficacy.
  • Many studies suffer from small sample sizes, lack of blinding, and are predominantly conducted in China, which may affect generalizability.
  • Poor oral bioavailability and challenges in chemical standardization complicate clinical application and interpretation.
  • Comprehensive safety and drug interaction data in humans remain insufficient.

References

Last Reviewed

June 2024

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before using herbal supplements, especially if you have underlying health conditions or are taking other medications.